Chargement de votre page…
Chaque registre avec son nombre de médicaments et quelques-uns d’entre eux.
Citez deux médicaments ou plus et Osler vérifie leurs interactions. Une interaction grave figure tout en haut de la réponse.
Health Canada · 10 médicaments
PHARMAC · 2 médicaments
AIFA · 1 médicament
Tous les registres, page par page. Dosages et conditionnements figurent sur la page de chaque médicament.
31 résultats
| Médicament | Registre | Dosage | Forme | Statut | Titulaire |
|---|---|---|---|---|---|
| Dextroamphetamine Sulfate | États-Unis | 5MG/5ML | solution | Commercialisé | Tris Pharma INC |
| Dextroamphetamine Sulfate | États-Unis | 10MG, 15MG, 5MG | capsule, extended release | Commercialisé | Specgx LLC |
| Dextroamphetamine Sulfate | États-Unis | 10MG, 15MG, 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Commercialisé | Aurolife Pharma LLC |
| Dexedrine Spansule | États-Unis | 10MG, 15MG, 5MG | capsule, extended release | Commercialisé | Impax Labs INC |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 1.875MG; 1.875MG; 1.875MG; 1.875MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | tablet | Commercialisé | Actavis Elizabeth |
| Dextroamp Saccharate, Amp Aspartate, Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 12.5MG; 12.5MG; 12.5MG; 12.5MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG … | capsule, extended release | Commercialisé | Ani Pharms |
| Dexampex | États-Unis | 10MG, 5MG | tablet | Non commercialisé | Teva |
| Dexampex | États-Unis | 15MG | capsule | Non commercialisé | Teva |
| Dexedrine | États-Unis | 5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | elixir | Non commercialisé | Glaxosmithkline |
| Dexedrine | États-Unis | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Glaxosmithkline |
| Adderall XR 10Association | États-Unis | 2.5MG; 2.5MG; 2.5MG; 2.5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 15Association | États-Unis | 3.75MG; 3.75MG; 3.75MG; 3.75MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 20Association | États-Unis | 5MG; 5MG; 5MG; 5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 25Association | États-Unis | 6.25MG; 6.25MG; 6.25MG; 6.25MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 30Association | États-Unis | 7.5MG; 7.5MG; 7.5MG; 7.5MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Adderall XR 5Association | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG | capsule, extended release | Commercialisé | Takeda Pharms USA |
| MydayisAssociation | États-Unis | 12.5MG; 12.5MG; 12.5MG; 12.5MG, 3.125MG; 3.125MG; 3.125MG; 3.125MG, 6.25MG; 6.25MG; 6.25MG; 6.25MG … | capsule, extended release | Commercialisé | Takeda Pharms USA |
| Xelstrym | États-Unis | 13.5MG/9HR, 18MG/9HR, 4.5MG/9HR … | system | Commercialisé | Noven Pharms INC |
| Dextrostat | États-Unis | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Shire |
| DelcobeseAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 2.5MG; 2.5MG; 2.5MG; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 3.75MG; 3.75MG; 3.75MG; 3.75MG **Federal Register determination that product was not discontinued or w | tablet | Non commercialisé | Teva |
| DelcobeseAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 2.5MG; 2.5MG; 2.5MG; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 3.75MG; 3.75MG; 3.75MG; 3.75MG **Federal Register determination that product was not discontinued or w | capsule | Non commercialisé | Teva |
| Dextroamp Saccharate,Amp Aspartate,Dextroamp Sulfate and Amp SulfateAssociation | États-Unis | 1.25MG; 1.25MG; 1.25MG; 1.25MG, 2.5MG; 2.5MG; 2.5MG; 2.5MG, 3.75MG; 3.75MG; 3.75MG; 3.75MG … | capsule, extended release | Non commercialisé | Barr Labs INC |
| Ferndex | États-Unis | 5MG | tablet | Non commercialisé | Ferndale Labs |
| Adderall 10Association | États-Unis | 2.5MG; 2.5MG; 2.5MG; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
| Adderall 12.5Association | États-Unis | 3.125MG; 3.125MG; 3.125MG; 3.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Non commercialisé | Teva Womens |
La même marque dans plusieurs registres.
Les laboratoires titulaires de ses médicaments, les plus importants d’abord.
Les substances avec lesquelles elle partage un médicament.
Comment les registres l’écrivent, dans leur propre langue.
Compilé par Prognia à partir des registres publics du médicament de AIFA, CBG-MEB, FDA, Health Canada et PHARMAC. La page de chaque médicament indique sa propre source, sa licence et son attribution.
Signaler une erreur ou demander un retraitLes corrections d’un registre ou d’un laboratoire sont les bienvenues.
Pour la consultation et l’apprentissage, pas un avis thérapeutique. Vérifiez toujours l’information officielle du produit.
